Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market Value if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). This option is intended to be an ISO or an NSO, as provided in the Notice of Stock Option Grant.

Option. Licensee shall have the one-time option (but not the obligation) to extend the Term through December 31, 2022 (the “Option”). In order to exercise the Option, Licensee must deliver to Licensor an irrevocable written notice of exercise during the period commencing April 1, 2021 and ending June 30, 2021 (the “Option Exercise Period”). If Licensee timely exercises the Option during the Option Exercise Period, then the Term shall automatically be extended through December 31, 2022 (the “Option Term”). If Licensee does not properly exercise the Option during the Option Exercise Period, then the Option will lapse and be of no further force or effect and the Term, subject to the month-to-month automatic renewals, will be scheduled to expire on December 31, 2021.

Option. Option shall mean a Non-Qualified Stock Option or an Incentive Stock Option granted pursuant to Section 6.2.

Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market Value if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). This option is intended to be an ISO or an NSO, as provided in the Notice of Stock Option Grant.

Option. "Option" means any option to subscribe for or purchase Ordinary Shares granted pursuant to this Plan.

Option. You may exercise the Option to buy all or any part of any Number of Shares of Common Stock which is then exercisable at the Exercise Price per share until the Expiration Date. This Option is not intended to qualify as an Incentive Stock Option.

Option. An Award may be in the form of an Option. An Option awarded pursuant to this Plan may consist of an Incentive Option or a Non-Qualified Option and will be designated accordingly at the time of grant. The price at which shares of Common Stock may be purchased upon the exercise of an Option shall be not less than the Fair Market Value of the Common Stock on the date of grant. The term of an Option shall not exceed ten years from the date of grant.

Option. “Option” shall have the meaning set forth in Section 6.1.

Option. XOMA hereby grants to [[AntriaBio:Organization]] an exclusive option to acquire an exclusive license to a single Option Product, selected by [[AntriaBio:Organization]], on equivalent terms and conditions and the same royalties and milestone payments as set forth herein, provided that in addition to such payments [[AntriaBio:Organization]] shall pay to XOMA: # a ​ option exercise fee, # a ​ payment on the ​, and # a ​ payment on the ​. [[AntriaBio:Organization]] may exercise such option at anytime prior to June 1, 2019 by providing XOMA with written notice of such exercise prior to such date specifying the Option Product selected by [[AntriaBio:Organization]] and accompanied by the option exercise fee. Following [[AntriaBio:Organization]]’s exercise of such option for an Option Product, XOMA shall have no further obligations to [[AntriaBio:Organization]] with respect to any other Option Product. If [[AntriaBio:Organization]] does not exercise such option by June 1, 2019, then XOMA shall have no further obligations to [[AntriaBio:Organization]] with respect to any Option Product. In addition, following [[AntriaBio:Organization]]’s exercise of its option with respect to an Option Product, XOMA shall have no further obligations to [[AntriaBio:Organization]] with respect to the Option Products not selected by [[AntriaBio:Organization]] in its exercise notice.

Option. The Company and the Option Holder hereby agree that neither the Option Holder nor any other Person shall exercise the Option at any time on or after the date of this Agreement unless and until this Agreement has been terminated in accordance with [Article IX], and any such purported exercise shall be deemed void and of no effect.